Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group (Q79162886)
Jump to navigation
Jump to search
scientific article published on 28 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group |
scientific article published on 28 September 2006 |
Statements
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group (English)
Nirdosh Kumar Gogna
John H L Matthews
Sandra L Turner
Hedy Mameghan
Nigel Spry
Martin P Berry
Jacqui Keller
Lee Tripcony
Trans Tasman Radiation Oncology Group
28 September 2006